Publication | Open Access
A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma
60
Citations
42
References
2020
Year
Hematological MalignancyAtm/atr/wee1 InhibitorsMedicineImmunologyPharmacologyCell DeathImmune Checkpoint InhibitorMultiple MyelomaOncologyNovel Bcma Pbd-adcCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1